Among the cohort studies, 2 scored three and five points, indicating low-quality studies with high and moderate risk of bias, respectively
Wegovy uses a semaglutide base with strict quality controls
This is the first study to suggest that GLP-1 RA use is associated with a small but significant 12% increased risk of developing chronic cough compared to treatment with other second-line agents for type 2 diabetes
For the step-by-step process of adding bacteriostatic water to your vial, see the retatrutide reconstitution guide
"Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA." The Lancet , 2023
Start with the benefits then understand how to incorporate it into your diet